Text Size
- News Releases
- What's New
- 18 Jan
- Chugai Supports the Japan Climate Initiative’s Calling to Raise 2030 Renewable Energy Target
- 12 Jan
- Chugai Conducts Digital Transformation in Manufacturing with IBM Japan to Realize a Digital Plant
- 28 Dec
- Chugai Obtains Approval for Expanded Use of FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic for Olaparib in BRCA- Mutated Prostate Cancer
- 25 Dec
- Chugai’s Hemlibra Wins the MHLW Minister's Award at the Fourth Japan Medical Research and Development Grand Prize
- 25 Dec
- Chugai Obtains Approval for Tecentriq as a Monotherapy for Chemotherapy-Naïve PD-L1-Positive Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Video Introduction of CHUGAI- Share this site
